89 related articles for article (PubMed ID: 27208803)
1. Prevalence and Predictors of Metformin Prescribing in Adults with Type 2 Diabetes Mellitus: A National Cross-Sectional Study.
Soric MM; Moorman JM; Boyle JA; Dengler-Crish CM
Pharmacotherapy; 2016 Jul; 36(7):715-22. PubMed ID: 27208803
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid Receptor Antagonist Utilization in a Nationally Representative Heart Failure With Reduced Ejection Fraction Outpatient Population: A Cross-Sectional Study.
Joyner KR; Soric MM; Boyle JA; Moorman JM; Fredrickson ME; Turosky JZ; Kleven CL
Am J Ther; 2020; 27(2):e165-e176. PubMed ID: 30074530
[TBL] [Abstract][Full Text] [Related]
3. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
Aquilante CL; Zhang W; McCollum M
Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Diabetes Screening and Prediabetes Treatment during Office Visits in the US.
Shealy KM; Wu J; Waites J; Taylor NA; Blair Sarbacker G
J Am Board Fam Med; 2019; 32(2):209-217. PubMed ID: 30850457
[TBL] [Abstract][Full Text] [Related]
5. Antihyperglycemic Medications: A Claims-Based Estimate of First-line Therapy Use Prior to Initialization of Second-line Medications.
Tseng YJ; Steinberg G; Fox KP; Armstrong J; Mandl KD
Diabetes Care; 2017 Nov; 40(11):1500-1505. PubMed ID: 28903978
[TBL] [Abstract][Full Text] [Related]
6. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
Kusturica J; Kulo Ćesić A; Gušić E; Maleškić S; Rakanović-Todić M; Šečić D
Med Glas (Zenica); 2017 Aug; 14(2):176-181. PubMed ID: 28698536
[TBL] [Abstract][Full Text] [Related]
7. Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin.
Shaya FT; Shin JY; Mullins D; Fatodu HO; Gu A; Saunders E
J Natl Med Assoc; 2005 Apr; 97(4):493-7. PubMed ID: 15868769
[TBL] [Abstract][Full Text] [Related]
8. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes.
Prentice JC; Conlin PR; Gellad WF; Edelman D; Lee TA; Pizer SD
Value Health; 2014 Dec; 17(8):854-62. PubMed ID: 25498781
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and characteristics of paediatric Type 2 diabetes in the Republic of Ireland.
O'Dea MI; O'Connell SM; O'Grady MJ
Diabet Med; 2017 Nov; 34(11):1603-1607. PubMed ID: 28703902
[TBL] [Abstract][Full Text] [Related]
11. Prescription trends and the selection of initial oral antidiabetic agents for patients with newly diagnosed type 2 diabetes: a nationwide study.
Liu CH; Chen ST; Chang CH; Chuang LM; Lai MS
Public Health; 2017 Nov; 152():20-27. PubMed ID: 28719837
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
13. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
[TBL] [Abstract][Full Text] [Related]
14. Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus.
Evans JM; Doney AS; AlZadjali MA; Ogston SA; Petrie JR; Morris AD; Struthers AD; Wong AK; Lang CC
Am J Cardiol; 2010 Oct; 106(7):1006-10. PubMed ID: 20854965
[TBL] [Abstract][Full Text] [Related]
15. Vitamin B12 deficiency and the lack of its consequences in type 2 diabetes patients using metformin.
de Groot-Kamphuis DM; van Dijk PR; Groenier KH; Houweling ST; Bilo HJ; Kleefstra N
Neth J Med; 2013 Sep; 71(7):386-90. PubMed ID: 24038568
[TBL] [Abstract][Full Text] [Related]
16. Prescribing trends for the outpatient treatment of adolescents and young adults with type 2 diabetes mellitus.
Phan H; Porter K; Sill B; Nahata MC
J Manag Care Pharm; 2012 Oct; 18(8):607-14. PubMed ID: 23127148
[TBL] [Abstract][Full Text] [Related]
17. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
18. Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?
Huang W; Castelino RL; Peterson GM
Intern Med J; 2014 Mar; 44(3):266-72. PubMed ID: 24405767
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study.
Abu-Ashour W; Chibrikova L; Midodzi WK; Twells LK; Gamble JM
Diabet Med; 2017 Feb; 34(2):229-234. PubMed ID: 26802577
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study.
Chang CH; Chang YC; Lin JW; Chen ST; Chuang LM; Lai MS
J Clin Endocrinol Metab; 2015 Mar; 100(3):1121-9. PubMed ID: 25555040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
